Cash & equivalents decreased 77.9%
Cash & equivalents changed -77.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$3.2B→$710.0M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MSI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 54.8%
Inventory changed +54.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$861.0M→$1.3B4 prior comparisons
Current liabilities increased 25.0%
Current liabilities changed +25.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$4.5B→$5.6B4 prior comparisons
Current ratio decreased 36.4%
Current ratio changed -36.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.73→1.14 prior comparisons
Current assets decreased 20.5%
Current assets changed -20.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$7.7B→$6.1B4 prior comparisons
Free-cash-flow proxy increased 84.0%
Free-cash-flow proxy changed +84.0% from the comparable as-filed period.
$225.0M→$414.0M2 prior comparisons
Operating cash flow increased 71.8%
Operating cash flow changed +71.8% from the comparable as-filed period.
$273.0M→$469.0M3 prior comparisons
Gross margin moved 246 bp higher
Gross margin changed +246 basis points from the comparable as-filed period.
51.10%→53.56%2 prior comparisons
Stockholders' equity increased 35.8%
Stockholders' equity changed +35.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.0B→$2.7B4 prior comparisons
Working capital decreased 83.0%
Working capital changed -83.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.3B→$553.0M4 prior comparisons
Operating income increased 16.9%
Operating income changed +16.9% from the comparable as-filed period.
$692.0M→$809.0M2 prior comparisons
Inventory / revenue moved 1141 bp higher
Inventory / revenue changed +1141 basis points from the comparable as-filed period.
31.14%→42.55%2 prior comparisons
Revenue increased 13.3%
Revenue changed +13.3% from the comparable as-filed period.
$2.8B→$3.1B2 prior comparisons
Operating margin moved 79 bp higher
Operating margin changed +79 basis points from the comparable as-filed period.
25.03%→25.82%2 prior comparisons
Free-cash-flow margin moved 508 bp higher
Free-cash-flow margin changed +508 basis points from the comparable as-filed period.
8.14%→13.21%2 prior comparisons
Operating cash-flow margin moved 510 bp higher
Operating cash-flow margin changed +510 basis points from the comparable as-filed period.
9.87%→14.97%2 prior comparisons
Stock-based compensation increased 40.5%
Stock-based compensation changed +40.5% from the comparable as-filed period.
$74.0M→$104.0M2 prior comparisons
Working capital / assets moved 1693 bp lower
Working capital / assets changed -1693 basis points from the comparable as-filed period.
19.80%→2.87%3 prior comparisons
Total assets increased 17.2%
Total assets changed +17.2% from the comparable as-filed period.
$16.4B→$19.2B3 prior comparisons
Gross profit increased 18.8%
Gross profit changed +18.8% from the comparable as-filed period.
$1.4B→$1.7B2 prior comparisons
Shares outstanding decreased 0.7%
Shares outstanding changed -0.7% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
166,603,894→165,493,7888 prior comparisons
Trade receivables increased 16.6%
Trade receivables changed +16.6% from the comparable as-filed period.
$1.9B→$2.2B3 prior comparisons
Operating cash flow / net income increased 58.2%
Operating cash flow / net income changed +58.2% from the comparable as-filed period.
0.53→0.842 prior comparisons
Noncurrent long-term debt increased 9.9%
Noncurrent long-term debt changed +9.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$7.7B→$8.4B4 prior comparisons
Net income increased 8.6%
Net income changed +8.6% from the comparable as-filed period.
$513.0M→$557.0M2 prior comparisons
Receivables / revenue moved 196 bp higher
Receivables / revenue changed +196 basis points from the comparable as-filed period.
66.98%→68.94%2 prior comparisons
Research & development increased 12.6%
Research & development changed +12.6% from the comparable as-filed period.
$231.0M→$260.0M2 prior comparisons
SBC / revenue moved 64 bp higher
SBC / revenue changed +64 basis points from the comparable as-filed period.
2.68%→3.32%2 prior comparisons
Selling, general & administrative increased 10.2%
Selling, general & administrative changed +10.2% from the comparable as-filed period.
$450.0M→$496.0M2 prior comparisons
Capex / revenue moved 2 bp higher
Capex / revenue changed +2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.74%→1.76%2 prior comparisons
Capital expenditure increased 14.6%
Capital expenditure changed +14.6% from the comparable as-filed period.
$48.0M→$55.0M2 prior comparisons
R&D / revenue moved 6 bp lower
R&D / revenue changed -6 basis points from the comparable as-filed period.
8.35%→8.30%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.